Out-of-pocket spending on specialty drugs dropped dramatically after states capped costs
A new analysis finds out-of-pocket spending caps in three states have helped residents save money on pricey specialty drugs.
Read The Story 
Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
Pharmalittle: Moderna gets $1.5 billion U.S. contract for Covid-19 vax; state out-of-pocket caps saved residents money
Pharmalittle: Russia registers a Covid-19 vaccine amid skepticism; can monoclonal antibodies combat the coronavirus?
